Publication & Citation Trends
Publications
0 total
Dual plasmepsin IX and X inhibitors are refractory to development of resistance
Cited by 0
Semantic Scholar
MK-7602: a potent multi-stage dual-targeting antimalarial
Cited by 2
Semantic Scholar
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria. OA
Cited by 14
Semantic Scholar
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting OA
Cited by 14
Semantic Scholar
4D analysis of malaria parasite invasion offers insights into erythrocyte membrane remodeling and parasitophorous vacuole formation OA
Cited by 50
Semantic Scholar
Pan-active imidazolopiperazine antimalarials target the falciparum intracellular secretory pathway.
Cited by 0
Semantic Scholar
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle OA
Cited by 119
Semantic Scholar
1 Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum 2 intracellular secretory pathway 3
Cited by 0
Semantic Scholar
Research Topics
Malaria Research and Control
(44)
Mosquito-borne diseases and control
(28)
Invertebrate Immune Response Mechanisms
(12)
Drug Transport and Resistance Mechanisms
(8)
Complement system in diseases
(7)
Affiliations
University College Dublin
University of North Carolina at Chapel Hill
Queen's University Belfast
BC Cancer Agency
The Royal Melbourne Hospital